Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CSL Behring
Age
40–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female patients ≥ 40 years of age
Documented diagnosis of IPF
You may not be if
History of clinically significant cardiovascular disease, including myocardial infarction, unstable ischemic heart disease, congestive heart failure, or angina during the 6 months before screening
Sinoatrial or atrioventricular block, uncontrolled hypertension
Active bleeding or current clinically significant coagulopathy
Clareo Health | Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis
